Novotech Sponsors BIO 2023 APAC Summit And The Endpoints Panel On Forging Biotech Ties With China

Boston, MA - Novotech, the leading Asia Pacific centred biotech CRO is sponsoring the BIO 2023 APAC Summit, and the Endpoints session on Forging New Biotech Ties with China.

Novotech CCO Barry Murphy is a panelist on the APAC Summit session Diversity and Beyond - Tapping the potential of the Asia Pacific for Clinical Trials.

Novotech, a biotech CRO with a global footprint and more than 25 years of clinical trial and drug development consulting services experience in the Asia Pacific region, was selected this month for the prestigious CRO Leadership Award 2023 for exceeding biotech customer expectations.

Meet with the Novotech team at BIO 2023 here

The APAC Summit will focus on the Asia Pacific region, which is home to more than 40% of the world’s population and is one of the most culturally diverse regions for clinical trials.

Over the last 10 years it has become an increasingly attractive destination for clinical trials contributing almost 50% of new clinical trial activity globally in 2022. 

The Summit will highlight the cross-border opportunities and exciting biomedical innovation from the APAC region through panel discussions. It brings together experts from industry and clinical trial institutions from the region to discuss the current state of play, and importantly, future developments and perspectives for successful clinical trial strategies in APAC.

Register via your BIO registration. All General Access and Premier Access registrants have access to the APAC Summit.